Study of the contrasting effectiveness of various tumors types using cubic magnetite nanoparticles
https://doi.org/10.20538/1682-0363-2018-1-139-148
Abstract
Currently magnetic resonance imaging (MRI) is one of the key diagnostics methods of various diseases. Utilizing various contrast agents based on magnetic nanoparticles can improve the diagnostic efficiency and, consequently, the quality of the subsequent treatment. The most promising contrast agents are cubic magnetite nanoparticles, due to their high relaxation rates, as well as biocompatibility and biodegradability.
Thereby, the purpose of this work was to evaluate the effectiveness of MRI imaging of tumors by cubic magnetite nanoparticles (CMN).
Materials and methods. For this purpose, the synthesis of 15 nm CMN modified with biocompatible copolymer plurlonic F127 was carried out. Synthesized CMN and their water colloids were characterized by a complex of physicochemical methods of analysis. Then, using MRI a study of the effectiveness of contrasting of various tumor types after intravenous administration of CMN aqueous colloids was made. Three models of mouse tumors were used for a comprehensive assessment of obtained results: breast cancer 4T1, colon cancer CT-26 and melanoma B16. MRI studies were performed prior to the administration of the particles, and also after 15 min, 6 hours and 24 hours after injection in T2-weighted regime in two mutually orthogonal projections.
Results. The analysis of the obtained results showed that the most effective accumulation of particles was found in the 4T1 (100%) and B16 (57%) models, and in the case of CT-26 model the accumulation efficiency was 50% due to the effect of the permeability of blood vessels.
About the Authors
A. A. NikitinRussian Federation
Nikitin Aleksey A., PhD-student; Еngineer.4, Leninskiy Av., Moscow, 119991; 1/3, Leninskiye Gory, GSP-1, Moscow, 119991.
V. A. Naumenko
Russian Federation
Naumenko Victor A., PhD, Еngineer.
4, Leninskiy Av., Moscow, 119991.
S. S. Vodopyanov
Russian Federation
Vodopyanov Stepan S., PhD, Еngineer.
4, Leninskiy Av., Moscow, 119991.
A. S. Garanina
Russian Federation
Garanina Anastasia S., PhD, Еngineer.
4, Leninskiy Av., Moscow, 119991.
N. D. Fedorova
Russian Federation
Fedorova Natalya D., Graduate Student.
4, Leninskiy Av., Moscow, 119991.
E. D. Kalabay
Russian Federation
Kalabay Enlik D., Graduate Student.
4, Leninskiy Av., Moscow, 119991.
A. G. Savchenko
Russian Federation
Savchenko Alexander G., PhD, Нead of the Department of Physical Materials Science.
4, Leninskiy Av., Moscow, 119991.
M. A. Abakumov
Russian Federation
Abakumov Maxim A., PhD, Head of the Department of Biomedical Nanomaterials.
4, Leninskiy Av., Moscow, 119991; 1, Ostrovityanova Str., Moscow, 117997.
A. G. Majouga
Russian Federation
Majouga Alexander G., Рrofessor, DChSc, Acting Rector of Dmitry Mendeleev University of Chemical Technology of Russia.
1/3, Leninskiye Gory, GSP-1, Moscow, 119991; 9, Miusskaya Str., Moscow, 125047.
References
1. Lee N. et al. Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy. Chemical Reviews. 2015; 115 (19): 10637–10689. DOI: 10.1021/acs.chemrev.5b00112.
2. Yigit M.V., Moore A., Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharmaceutical Research. 2012; 29 (5): 1180–1188. DOI:10.1007/s11095012-0679-7.
3. Josephson L. et al. The effects of iron oxides on proton relaxivity. Magn. Reson. Imaging. 1988; 6 (6): 647–653.
4. Ramalho J. et al. Gadolinium-based contrast agent accumulation and toxicity: An update. American Journal of Neuroradiology. 2016; 37 (7): 1192–1198. DOI:10.3174/ ajnr.A4615.
5. Kievit F.M., Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc. Chem. Res. 2011; 44 (10): 853–862. DOI:10.1021/ar2000277.
6. Jun Y.W. et al. Nanoscale Size Effect of Magnetic Nanocrystals and Their Utilization for Cancer Diagnosis via Magnetic Resonance Imaging. J. Am. Chem. Soc. 2005; 127 (16): 5732–5733. DOI: 10.1021/ja0422155.
7. Brooks R.A., Moiny F., Gillis P. On T2-shortening by strongly magnetized spheres: A partial refocusing model. Magn. Reson. Med. 2002; 47 (2): 257–263.
8. Zhen G. et al. Comparative Study of the Magnetic Behavior of Spherical and Cubic Superparamagnetic Iron Oxide Nanoparticles. J. Phys. Chem. C. 2011; 115 (2): 327–334. DOI: 10.1021/jp104953z.
9. Lee N. et al. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r 2 relaxivity for highly sensitive in vivo MRI of tumors. Nano Lett. 2012; 12 (6): 3127–3131. DOI:10.1021/nl3010308.
10. Batrakova E.V., Kabanov A.V. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. Journal of Controlled Release. 2008; 130 (2): 98–106. DOI: 10.1016/j.jconrel.2008.04.013.
11. Nakamura Y. et al. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? Bioconjugate Chemistry. 2016; 27 (10): 2225–2238. DOI: 10.1021/acs.bioconjchem.6b00437.
12. Bertrand N. et al. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews. 2014; 66: 2–25. DOI: 10.1016/j.addr.2013.11.009.
13. Riemer J. et al. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 2004; 331 (2): 370–375. DOI: 10.1016/j.ab.2004.03.049.
14. Nikitin A. et al. Synthesis, characterization and MRI application of magnetite water-soluble cubic nanoparticles. J. Magn. Magn. Mater. 2017; 441: 6–13. DOI:10.1016/j. jmmm.2017.05.039.
Review
For citations:
Nikitin A.A., Naumenko V.A., Vodopyanov S.S., Garanina A.S., Fedorova N.D., Kalabay E.D., Savchenko A.G., Abakumov M.A., Majouga A.G. Study of the contrasting effectiveness of various tumors types using cubic magnetite nanoparticles. Bulletin of Siberian Medicine. 2018;17(1):139-148. (In Russ.) https://doi.org/10.20538/1682-0363-2018-1-139-148